Center for Human Reproduction is a private fertility center in New York City, widely recognized worldwide for its clinical research program. Past research at CHR has contributed many major clinical breakthroughs to infertility treatment, including IVF treatment and treatment of diminished ovarian reserve.
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Screening and Treatment
NEW YORK, Sept. 12, 2012 /PRNewswire/ — BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and […]
NEW YORK, May 31, 2011 — A New York IVF center warns against simplistic interpretation of a recent report on IVF pregnancy rates, published online in the medical journal Human Reproduction. The paper(1) reported that maximal birth rates were achieved when 15 to 20 oocytes (eggs) were retrieved in an IVF cycle. A press release(2) […]
In IVF Cycles, Endometrium Dramatically Improves After Treatment with G-CSF, New Research Suggests
NEW YORK, Feb. 23, 2011 — During in vitro fertilization (IVF) cycles, treatment with a medication called granulocyte-colony stimulating factor (G-CSF) significantly improves inadequate endometrium (lining of the uterus), according to a report published electronically on February 15 in Fertility and Sterility – the official journal of the American Society for Reproductive Medicine (ASRM). The […]
